Jianqiang Guo

Huainan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

High-throughput microfluidics and machine learning-assisted screening of lipid nanoparticle formulations for siRNA delivery.

High-throughput microfluidics and machine learning-assisted screening of lipid nanoparticle formulations for siRNA delivery.

Journal: Materials today. Bio
Published: February 13, 2026

Abrogation of PDE7A ameliorates alveolar epithelial EMT-Driven pulmonary fibrosis.

Abrogation of PDE7A ameliorates alveolar epithelial EMT-Driven pulmonary fibrosis.

Journal: Biochemical pharmacology
Published: November 19, 2025

Cortex Mori Radicis Mitigates Inflammation and Fibrosis in Pulmonary Fibrosis Through PI3K/AKT Pathway Suppression.

Cortex Mori Radicis Mitigates Inflammation and Fibrosis in Pulmonary Fibrosis Through PI3K/AKT Pathway Suppression.

Journal: Canadian respiratory journal
Published: August 12, 2025

The research on the mechanism of GBP2 promoting the progression of silicosis by inducing macrophage polarization and epithelial cell transformation

The research on the mechanism of GBP2 promoting the progression of silicosis by inducing macrophage polarization and epithelial cell transformation

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: July 07, 2025

BI-2536 attenuates IPF progression by inhibiting the PLK2/JNK/SP1 Signaling pathway in AT2 cells.

BI-2536 attenuates IPF progression by inhibiting the PLK2/JNK/SP1 Signaling pathway in AT2 cells.

Journal: International immunopharmacology
Published: May 27, 2025

Luteolin targets peroxiredoxin 2 to augment T-cell-mediated cytotoxicity and suppress lung adenocarcinoma progression.

Luteolin targets peroxiredoxin 2 to augment T-cell-mediated cytotoxicity and suppress lung adenocarcinoma progression.

Journal: European journal of pharmacology
Published: April 15, 2025

Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K/AKT/SP1 pathway.

Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K/AKT/SP1 pathway.

Journal: Journal of translational medicine
Published: February 27, 2025

Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention.

Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention.

Journal: Cellular signalling
Published: December 31, 2024

Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis.

Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis.

Journal: International immunopharmacology
Published: December 26, 2024

SSBP1 positively regulates RRM2, affecting epithelial mesenchymal transition and cell cycle arrest in human lung adenocarcinoma cells.

SSBP1 positively regulates RRM2, affecting epithelial mesenchymal transition and cell cycle arrest in human lung adenocarcinoma cells.

Journal: Cellular signalling
Published: October 15, 2024

The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma.

The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma.

Journal: Gene
Published: September 25, 2024

KIF2C as a potential therapeutic target: insights from lung adenocarcinoma subtype classification and functional experiments.

KIF2C as a potential therapeutic target: insights from lung adenocarcinoma subtype classification and functional experiments.

Journal: Molecular omics
Published: June 28, 2024
Showing 1-12 of 40

Last Updated: 09/26/2026